Search

Search Constraints

You searched for: Author/Creator Samouëlian, Vanessa

Search Results

2. 2022-RA-1198-ESGO Post hoc analysis of objective response rate by mismatch repair protein dimer loss/mutation status in patients with mismatch repair deficient endometrial cancer treated with dostarlimab. (20th October 2022)

3. 2022-RA-1432-ESGO Economical impact of ERAS implementation in a high-volume gynecologic oncology surgery division in Canada. (20th October 2022)

5. 2022-RA-1699-ESGO ERAS pathway for gynecological oncology – a pre-post implementation cohort with 1211 patients. (20th October 2022)

6. 2022-RA-1702-ESGO Opioid prescription adequacy in endometrial cancer patients undergoing hysterectomy under ERAS protocol. (20th October 2022)

7. 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial. (20th October 2022)

8. A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher. Issue 4 (14th December 2021)

9. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer. Issue 2 (1st February 2016)

10. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer. Issue 2 (February 2016)